1. A contemporary, nationwide analysis of surgery and radiotherapy treatment for prostate cancer. (5th September 2019) Authors: Roberts, Matthew J.; Papa, Nathan; Perera, Marlon; Scott, Susan; Teloken, Patrick E.; Joshi, Andre; Vela, Ian; Pryor, David; Martin, Jarad; Woo, Henry Journal: BJU international Issue: Volume 124(2019)Supplement 1 Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of the use of the Internet and social media among people with bladder cancer and their carers, and the quality of available patient‐centric online resources: a systematic review. (23rd April 2019) Authors: Tariq, Amina; Khan, Shanchita R.; Vela, Ian; Williams, Elizabeth D. Journal: BJU international Issue: Volume 123(2019)Supplement 5 Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Challenges, applications and future directions of precision medicine in prostate cancer – the role of organoids and patient‐derived xenografts. (30th May 2020) Authors: Joshi, Andre; Roberts, Matthew J.; Alinezhad, Saeid; Williams, Elizabeth D.; Vela, Ian Journal: BJU international Issue: Volume 126:Number 1(2020) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials. Issue 2 (19th November 2015) Authors: Teleni, Laisa; Chan, Raymond J; Chan, Alexandre; Isenring, Elisabeth A; Vela, Ian; Inder, Warrick J; McCarthy, Alexandra L Journal: Endocrine-related cancer Issue: Volume 23:Issue 2(2016) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Large variation in conservative management of low‐risk prostate cancer in Australia and New Zealand. (21st February 2022) Authors: Ong, Wee Loon; Thangasamy, Isaac; Murphy, Declan; Pritchard, Elizabeth; Evans, Susan; Millar, Jeremy; Chalasani, Venu; Rashid, Prem; Winter, Matthew; Vela, Ian; Pryor, David; Mark, Stephen; Lawrentschuk, Nathan Journal: BJU international Issue: Volume 130(2022)Supplement 1 Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Modelling the tumor immune microenvironment for precision immunotherapy. Issue 6 (26th June 2022) Authors: Mackenzie, Nathan J; Nicholls, Clarissa; Templeton, Abby R; Perera, Mahasha PJ; Jeffery, Penny L; Zimmermann, Kate; Kulasinghe, Arutha; Kenna, Tony J; Vela, Ian; Williams, Elizabeth D; Thomas, Patrick B Journal: Clinical & translational immunology Issue: Volume 11:Issue 6(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prostate cancer organoids: a potential new tool for testing drug sensitivity. Issue 3 (March 2014) Authors: Vela, Ian; Chen, Yu Journal: Expert review of anticancer therapy Issue: Volume 15:Issue 3(2015) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Issue 10231 (11th April 2020) Authors: Hofman, Michael S; Lawrentschuk, Nathan; Francis, Roslyn J; Tang, Colin; Vela, Ian; Thomas, Paul; Rutherford, Natalie; Martin, Jarad M; Frydenberg, Mark; Shakher, Ramdave; Wong, Lih-Ming; Taubman, Kim; Ting Lee, Sze; Hsiao, Edward; Roach, Paul; Nottage, Michelle; Kirkwood, Ian; Hayne, Dickon; Lin... Journal: Lancet Issue: Volume 395:Issue 10231(2020) Page Start: 1208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. UpFrontPSMA: a randomized phase 2 study of sequential 177Lu‐PSMA‐617 and docetaxel vs docetaxel in metastatic hormone‐naïve prostate cancer (clinical trial protocol). (21st April 2021) Authors: Dhiantravan, Nattakorn; Emmett, Louise; Joshua, Anthony M.; Pattison, David A.; Francis, Roslyn J.; Williams, Scott; Sandhu, Shahneen; Davis, Ian D.; Vela, Ian; Neha, Nitika; Bressel, Mathias; Murphy, Declan G.; Hofman, Michael S.; Azad, Arun A. Journal: BJU international Issue: Volume 128:Number 3(2021) Page Start: 331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Urachal Mucinous Cystadenocarcinoma. Issue 1 (22nd January 2019) Authors: Pereira, Ryan; McGeorge, Stephen; Perera, Marlon; Vela, Ian Journal: BMJ case reports Issue: Volume 12:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗